Sirolimus-eluting balloon with provisional stenting is noninferior to systematic drug-eluting stent implantation for target vessel failure at 1 year in de novo coronary lesions.
- 13 cites
Moving in Circulation.
Rebuilt
Sirolimus-eluting balloon with provisional stenting is noninferior to systematic drug-eluting stent implantation for target vessel failure at 1 year in de novo coronary lesions.
Newest first · last 60 days
Coronary computed tomography angiography-derived fractional flow reserve (FFR-CT) predicts future cardiovascular events with significant accuracy, especially below a threshold of 0.67, in a large nationwide cohort.
Functional coronary angiography-guided revascularization reduces primary-outcome events by 38% compared to conventional angiography in STEMI patients with multivessel disease.
Performing TAVI before PCI is noninferior to PCI before TAVI regarding 1-year outcomes in patients with severe aortic stenosis and coronary artery disease, with a 22.2% versus 24.2% event rate.
Potent P2Y12 inhibitors combined with DOACs increase bleeding risk without reducing ischemic events in atrial fibrillation and acute coronary syndrome patients.
Sirolimus-coated balloon angioplasty reduces major adverse limb events by 4.9 percentage points compared to uncoated balloons in infrainguinal artery disease patients.
Journals this month
Moving areas, week to 3 Oct 2026